When it comes to vaccination campaigns, there is an urgent need for message discipline to be strictly maintained. For example, during the COVID-19 pandemic, it was vital that people understood the types of COVID-19 vaccines that have been developed, the rigorous testing process that has been undertaken, and why it is important that all eligible…
Idiopathic pulmonary fibrosis (IPF) and lung cancer are often viewed as 2 separate diseases, each with its own pathophysiology. However, recent studies have suggested they are more alike than previously acknowledged. Lung cancer is one of the leading causes of cancer-related deaths across the globe, and patients with IPF are at a higher risk of…
Environmental scientists have been warning us for a long time that climate change and air pollution are having a negative impact on our health. However, medical research attempting to associate environmental factors with the risk of developing certain diseases is scarce. Why is this? Perhaps medical researchers see environmental science as something outside their field…
Researchers are increasingly exploring the potential of gene therapy in treating respiratory diseases.
Various researchers have chronicled how our understanding of idiopathic pulmonary fibrosis has undergone tremendous changes over the years.
Researchers explain why they believe visual analog scales are ideal assessment tools for understanding patients’ experiences.
We explore the vast medical challenge of treating the combination of idiopathic pulmonary fibrosis and pulmonary hypertension successfully.
We explore how telomere dysfunction potentially drives the pathogenesis of idiopathic pulmonary fibrosis, and what that could mean for future research.
We explore the pathological processes that result in the fibrosis of the lungs in patients with idiopathic pulmonary fibrosis.
We explore a proposed medical algorithm for diagnosing acute exacerbations of IPF and discuss the use of medical algorithms in general.